Di Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Di Wu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Jun Qi
Department of Computing, Xian Jiaotong-Liverpool University, Suzhou, China
2 shared publications Bing-Jie Ma
Department of Pain Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication- Ding Xu
Department of Urology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication Dong-Ya Wang
Department of Urology, Huadong Hospital Affiliated to Fudan University, Shanghai, China
1 shared publicationHai-Xiao Tang
Department of Urology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 20092, China
1 shared publication- Hai-Xiao Tang
Department of Urology Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai China
1 shared publication
Latest Publications
- Open Access
- 1 May 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (5) , 149
Holmium laser enucleation of the prostate improves the renal insufficiency of benign prostatic hyperplasia with hydronephrosis
Background: Hydronephrosis is a serious long-term complication of benign prostatic hyperplasia (BPH), and patients with this condition are prone to suffer from renal insufficiency. This study was performed to evaluate the efficacy of holmium laser enucleation of the prostate (HoLEP) for renal dysfunction in BPH patients with hydronephrosis. Methods: In this retrospective cohort study, the enrolled 122 patients were divided into two groups according to the type of surgery: HoLEP (n=64) or bipolar plasmakinetic transurethral resection of the prostate (TURP, n=58). Perioperative indicators and follow-up variables were analysed to evaluate the efficacy and durability of HoLEP. Results: The HoLEP group had a shorter operation time, bladder irrigation time, catheterization duration and hospital stays; less haemoglobin (Hb) and sodium decrease; and greater tissue removal (PConclusions: Therefore, by more safely and completely removing the hyperplastic prostate tissue to ensure durable relief of lower urinary tract obstruction, HoLEP can effectively and continuously benefit the recovery of renal function in BPH patients with preoperative hydronephrosis, and it is expected to become the ideal surgical intervention for these patients.
- 1 May 2026
- Published by AME Publishing Company in Translational Andrology and Urology
- Vol. 15 (5) , 149
Open AccessHolmium laser enucleation of the prostate improves the renal insufficiency of benign prostatic hyperplasia with hydronephrosis
Background: Hydronephrosis is a serious long-term complication of benign prostatic hyperplasia (BPH), and patients with this condition are prone to suffer from renal insufficiency. This study was performed to evaluate the efficacy of holmium laser enucleation of the prostate (HoLEP) for renal dysfunction in BPH patients with hydronephrosis. Methods: In this retrospective cohort study, the enrolled 122 patients were divided into two groups according to the type of surgery: HoLEP (n=64) or bipolar plasmakinetic transurethral resection of the prostate (TURP, n=58). Perioperative indicators and follow-up variables were analysed to evaluate the efficacy and durability of HoLEP. Results: The HoLEP group had a shorter operation time, bladder irrigation time, catheterization duration and hospital stays; less haemoglobin (Hb) and sodium decrease; and greater tissue removal (PConclusions: Therefore, by more safely and completely removing the hyperplastic prostate tissue to ensure durable relief of lower urinary tract obstruction, HoLEP can effectively and continuously benefit the recovery of renal function in BPH patients with preoperative hydronephrosis, and it is expected to become the ideal surgical intervention for these patients.
- 23 August 2020
- Published by Wiley in Andrologia
- Vol. 52 (11) , e13763
The possible association between serum interleukin 8 and acute urinary retention in Chinese patients with benign prostatic hyperplasia
Acute urinary retention (AUR) is one of the progressive manifestations of benign prostatic hyperplasia (BPH). This cross‐sectional study was conducted to analyse the possible association between serum interleukin 8 (sIL‐8) and AUR in BPH patients to provide evidence of sIL‐8 as a potential biomarker for the prediction of AUR. The relationship between sIL‐8 levels and AUR was evaluated by logistic regressions in 245 ageing Chinese men with BPH. The discriminant validity of sIL‐8 and the optimal cut‐off value were determined by a receiver operating characteristic curve. The levels of sIL‐8 increased significantly in BPH patients with AUR (p < 0.001). The sIL‐8 concentration was positively correlated with AUR in BPH patients (OR = 1.024, 95% CI: 1.009–1.040, p = 0.002). The correlation with AUR in the group with a high sIL‐8 level (≥43.05 pg/ml) was significantly enhanced (OR = 8.853, 95% CI: 2.433–32.205, p = 0.001). The sIL‐8 level correlated with AUR in Chinese BPH patients independently. As a possible predictor, sIL‐8 may contribute to the screening of high‐risk populations for AUR to create opportunities for the early effective interventions to improve prognosis and enhance the quality of life. Prospective studies are needed to support all these results.
- 23 August 2020
- Published by Wiley in Andrologia
- Vol. 52 (11) , e13763
The possible association between serum interleukin 8 and acute urinary retention in Chinese patients with benign prostatic hyperplasia
Acute urinary retention (AUR) is one of the progressive manifestations of benign prostatic hyperplasia (BPH). This cross‐sectional study was conducted to analyse the possible association between serum interleukin 8 (sIL‐8) and AUR in BPH patients to provide evidence of sIL‐8 as a potential biomarker for the prediction of AUR. The relationship between sIL‐8 levels and AUR was evaluated by logistic regressions in 245 ageing Chinese men with BPH. The discriminant validity of sIL‐8 and the optimal cut‐off value were determined by a receiver operating characteristic curve. The levels of sIL‐8 increased significantly in BPH patients with AUR (p < 0.001). The sIL‐8 concentration was positively correlated with AUR in BPH patients (OR = 1.024, 95% CI: 1.009–1.040, p = 0.002). The correlation with AUR in the group with a high sIL‐8 level (≥43.05 pg/ml) was significantly enhanced (OR = 8.853, 95% CI: 2.433–32.205, p = 0.001). The sIL‐8 level correlated with AUR in Chinese BPH patients independently. As a possible predictor, sIL‐8 may contribute to the screening of high‐risk populations for AUR to create opportunities for the early effective interventions to improve prognosis and enhance the quality of life. Prospective studies are needed to support all these results.
- Open Access
- 8 July 2020
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-15
Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis
Background: Celastrol has been proven effective in anti-inflammatory but was limited in the clinic due to the poor solubility and side effects induced by low bioavailability. Osteoarthritis has acidic and inflammatory environment. Our aim was to load celastrol into HMSNs and capped with chitosan to construct a pH-responsive nanoparticle medicine (CSL@HMSNs-Cs), which is of high solubility for osteoarthritis intra-articular injection treatment. Methods: The CSL@HMSNs-Cs were assembled and the characteristics were measured. The CSL@HMSNs-Cs was applied in vitro in the chondrocytes collected from rats cartilage tissue and in vivo in the MIA induced knee osteoarthritis rats via intra-articular injection. Cytotoxicity assay, pH-responsive release, pain behavior, MRI, safranin o fast green staining, ELISA and western blot analysis were applied to evaluate the bioavailability and therapeutic effect of CSL@HMSNs-Cs. Results: CSL@HMSNs-Cs was stable due to the protection of the chitosan layers in alkaline environment (pH = 7.7) but revealed good solubility and therapeutic effect in acidic environment (pH = 6.0). The cytotoxicity assay showed no cytotoxicity at relatively low concentration (200 μg/mL) and the cell viability of chondrocytes stimulated by IL-1β was increased in CSL@HMSNs-Cs group. Paw withdrawal threshold in CSL@HMSNs-Cs group is increased, and MRI and Safranin O Fast Green staining showed improvements in articular surface erosion and joint effusion. The upregulated expression levels of IL-1β, TNF-α, IL-6, MMP-3 and MMP-13 and NF-κB signaling pathway of chondrocytes were inhibited in CSL@HMSNs-Cs group. Conclusion: Hollow mesoporous silica nanoparticles were an ideal carrier for natural drugs with poor solubility and were of high biocompatibility for intra-articular injection. These intra-articular injectable CSL@HMSNs-Cs with improved solubility, present a pH-responsive therapeutic strategy against osteoarthritis.
- 8 July 2020
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 18 (1) , 1-15
Open AccessIntra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis
Background: Celastrol has been proven effective in anti-inflammatory but was limited in the clinic due to the poor solubility and side effects induced by low bioavailability. Osteoarthritis has acidic and inflammatory environment. Our aim was to load celastrol into HMSNs and capped with chitosan to construct a pH-responsive nanoparticle medicine (CSL@HMSNs-Cs), which is of high solubility for osteoarthritis intra-articular injection treatment. Methods: The CSL@HMSNs-Cs were assembled and the characteristics were measured. The CSL@HMSNs-Cs was applied in vitro in the chondrocytes collected from rats cartilage tissue and in vivo in the MIA induced knee osteoarthritis rats via intra-articular injection. Cytotoxicity assay, pH-responsive release, pain behavior, MRI, safranin o fast green staining, ELISA and western blot analysis were applied to evaluate the bioavailability and therapeutic effect of CSL@HMSNs-Cs. Results: CSL@HMSNs-Cs was stable due to the protection of the chitosan layers in alkaline environment (pH = 7.7) but revealed good solubility and therapeutic effect in acidic environment (pH = 6.0). The cytotoxicity assay showed no cytotoxicity at relatively low concentration (200 μg/mL) and the cell viability of chondrocytes stimulated by IL-1β was increased in CSL@HMSNs-Cs group. Paw withdrawal threshold in CSL@HMSNs-Cs group is increased, and MRI and Safranin O Fast Green staining showed improvements in articular surface erosion and joint effusion. The upregulated expression levels of IL-1β, TNF-α, IL-6, MMP-3 and MMP-13 and NF-κB signaling pathway of chondrocytes were inhibited in CSL@HMSNs-Cs group. Conclusion: Hollow mesoporous silica nanoparticles were an ideal carrier for natural drugs with poor solubility and were of high biocompatibility for intra-articular injection. These intra-articular injectable CSL@HMSNs-Cs with improved solubility, present a pH-responsive therapeutic strategy against osteoarthritis.
- Open Access
- 1 January 2020
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (21) , 9808-9829
Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer
Rationale: Prostate cancer has become one of the most threatening malignant tumors in men, leading to an imperative need to develop effective and safe therapies. Because of the unique metabolism of tumor cells, the tumor microenvironment (TME) exhibits distinctive properties compared with normal tissues, among which the pH difference has been utilized as an ideal antitumor strategy. Herein, we introduce a reactive oxygen species (ROS)-controlled-release nanosystem with TME-responsiveness by applying hollow mesoporous silica nanoparticles (HMSNs) as carriers loaded with calcium peroxide (CaO2) and coated with polyacrylic acid (PAA) to construct the functional material CaO2@HMSNs-PAA. The differences in pH values and exogenous ROS scavenging abilities between the tumor tissue and normal tissues and the dual pH-responsiveness from CaO2 and PAA lay a scientific foundation for the application of CaO2@HMSNs-PAA in the tumor-selective therapy for prostate cancer.
- 1 January 2020
- Published by Ivyspring International Publisher in Theranostics
- Vol. 10 (21) , 9808-9829
Open AccessEfficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer
Rationale: Prostate cancer has become one of the most threatening malignant tumors in men, leading to an imperative need to develop effective and safe therapies. Because of the unique metabolism of tumor cells, the tumor microenvironment (TME) exhibits distinctive properties compared with normal tissues, among which the pH difference has been utilized as an ideal antitumor strategy. Herein, we introduce a reactive oxygen species (ROS)-controlled-release nanosystem with TME-responsiveness by applying hollow mesoporous silica nanoparticles (HMSNs) as carriers loaded with calcium peroxide (CaO2) and coated with polyacrylic acid (PAA) to construct the functional material CaO2@HMSNs-PAA. The differences in pH values and exogenous ROS scavenging abilities between the tumor tissue and normal tissues and the dual pH-responsiveness from CaO2 and PAA lay a scientific foundation for the application of CaO2@HMSNs-PAA in the tumor-selective therapy for prostate cancer.